| Name | Title | Contact Details |
|---|---|---|
Tammy Carrea |
Vice President of Quality and Regulatory Affairs | Profile |
Jasminder Brar |
Vice President of Legal, Intellectual Property, Strategic Initiatives and General Counsel | Profile |
Lasergen is an emerging biotechnology company focused on commercializing novel technologies for DNA sequencing. Our expertise in nucleotide chemistry and next-generation sequencing has led to a number of key discoveries resulting in both game-changing sequencing chemistry (Lightning Terminators™) and a more accurate sequencing platform. While focusing on the development of current cutting-edge technology, our continued drive for innovation and extensive sequencing knowledge allows us to rapidly evolve and keep pace with fast-changing advances in the sequencing industry.
Safecross First Aid Ltd. is a North York, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Exo (pronounced “Echo”) is pioneering a high-performance handheld ultrasound platform and AI for imaging and therapeutic applications.
Epione Medical Corporation is a Beverly Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Lombard Medical Technologies (LMT) develops, manufactures and markets stent grafts for the treatment of abdominal and thoracic aortic aneurysms, endovascular stapling devices for the fixation of stent grafts and percutaneous heart valves, and develops drug delivery coatings. The Company was established in July 2000 and currently employs over 100 people at Didcot, Sheffield and Ayrshire in the UK and in the USA. The Company also has trade investments in an emerging medical device company. Lombard Medical Technologies PLC is listed on the London Stock Exchange (AIM) under the symbol LMT.